Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

China

The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang

The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang

Huzhou Central Hospital, Huzhou, Zhejiang

Lishui Central Hospital, Lishui, Zhejiang

Ningbo First Hospital, Ningbo, Zhejiang

Ningbo Medical Center LiHuiLi Hospital, Ningbo, Zhejiang

Ningbo Second Hospital, Ningbo, Zhejiang

Taizhou Hospital, Taizhou, Zhejiang